BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6278507)

  • 1. Effects of a synthetic Met5-enkephalin analog on plasma luteinizing hormone and prolactin levels in conscious orchiectomized rats.
    Kato Y; Hiroto S; Katakami H; Matsushita N; Shimatsu A; Imura H
    Proc Soc Exp Biol Med; 1982 Jan; 169(1):95-100. PubMed ID: 6278507
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a met-enkephalin analogue and naloxone infusion on gonadotrophin secretion in man.
    Delitala G; Giusti M; Devilla L; Mazzocchi G; Lotti G; Giordano G
    Acta Eur Fertil; 1981 Sep; 12(3):287-8. PubMed ID: 6803502
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in pituitary hormone levels induced by met-enkephalin in man--the role of dopamine.
    Delitala G; Grossman A; Besser GM
    Life Sci; 1981 Oct; 29(15):1537-44. PubMed ID: 6795405
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of tolerance in heroin-addicts to the neuroendocrine effects of an enkephalin analogue.
    Brambilla F; Casanueva F; Lovati C; Peñalva A; Madeddu A; Martinez-Campos A; Müller EE
    Life Sci; 1981 Aug; 29(5):493-501. PubMed ID: 6792439
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma LH, FSH and TSH responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases.
    Demura R; Suda T; Wakabayashi I; Ono M; Jibiki K; Odagiri E; Demura H; Shizume K
    Tohoku J Exp Med; 1982 Jul; 137(3):283-7. PubMed ID: 6810504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The met-enkephalin analog FK 33-824 directly inhibits ACTH release by the rat pituitary gland in vitro.
    Lamberts SW; Janssens EN; Bons EG; Uitterlinden P; Zuiderwijk JM; Del Pozo E
    Life Sci; 1983 Mar; 32(11):1167-73. PubMed ID: 6300576
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible involvement of gamma-aminobutyric acid in growth hormone release induced by a Met5-enkephalin analog in conscious rats.
    Katakami H; Kato Y; Matsushita N; Shimatsu A; Imura H
    Endocrinology; 1981 Oct; 109(4):1033-6. PubMed ID: 7285858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and EEG effects of synthetic enkephalin analogue (FK 33-824).
    Bo P; Maurelli M; Nappi G; Savoldi F
    Farmaco Sci; 1980 Nov; 35(11):924-32. PubMed ID: 6450058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the anticonvulsant effects of two systemically active enkephalin analogues in rats.
    Cowan A; Tortella FC; Adler MW
    Eur J Pharmacol; 1981 Apr; 71(1):117-21. PubMed ID: 7238580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methionine enkephalin on prolactin and luteinizing hormone levels in intact and castrated rats.
    Goldberg R; Conforti N; Spitz IM
    Horm Metab Res; 1982 Feb; 14(2):89-92. PubMed ID: 7068102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of alpha-adrenergic mechanisms in growth hormone release induced by opioid peptides in conscious rats.
    Katakami H; Kato Y; Matsushita N; Hiroto S; Shimatsu A; Imura H
    Neuroendocrinology; 1981 Sep; 33(3):129-35. PubMed ID: 6117022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.
    Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
    Eur J Pharmacol; 1981 Dec; 76(2-3):235-9. PubMed ID: 6277644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A puberty-related attenuation of opiate peptide-induced inhibition of LH secretion.
    Wilkinson M; Bhanot R
    Endocrinology; 1982 Mar; 110(3):1046-8. PubMed ID: 7056220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACTH1-24 counteracts the prolactin-releasing effect of an opioid.
    Ferri S; Cocchi D; Locatelli V; Spampinato S; Muller E
    Eur J Pharmacol; 1982 Jan; 77(2-3):143-5. PubMed ID: 6277660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxone.
    Grossman A; Moult PJ; Gaillard RC; Delitala G; Toff WD; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):41-7. PubMed ID: 6784982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between opioid peptides and pituitary hormones.
    Ferri S; Candeletti S; Cocchi D; Giagnoni G; Rossi T; Scoto G; Spampinato S
    Adv Biochem Psychopharmacol; 1982; 33():109-15. PubMed ID: 6289620
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of prolactin secretion in the rat by alpha-neo-endorphin, beta-neo-endorphin and dynorphin.
    Matsushita N; Kato Y; Shimatsu A; Katakami H; Fujino M; Matsuo H; Imura H
    Biochem Biophys Res Commun; 1982 Jul; 107(2):735-41. PubMed ID: 6127078
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppressive effect of dynorphin-(1-13) on luteinizing hormone release in conscious castrated rats.
    Kinoshita F; Nakai Y; Katakami H; Imura H
    Life Sci; 1982 May; 30(22):1915-9. PubMed ID: 6287134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of brain dopamine in prolactin secretion induced by a synthetic Met5-enkephalin analogue in rats.
    Matsushita N; Kato Y; Katakami H; Shimatsu A; Imura H
    Endocrinol Jpn; 1982 Jun; 29(3):277-85. PubMed ID: 7173110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.